Lv5
856 积分 2023-07-27 加入
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization
1天前
已完结
Association of Semaglutide Treatment With Liver Cirrhosis and Hepatocellular Carcinoma in Type 2 Diabetes: A Population‐Based Cohort Study
1天前
已完结
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
1天前
已完结
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown
1天前
已完结
AASLD ISDA Practice Guideline on treatment of chronic hepatitis B
2天前
已完结
Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B
2天前
已完结
Antiviral Therapy Reduces Hepatocellular Carcinoma and Cirrhosis Risk in Chinese Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase
2天前
待确认
Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure
2天前
已完结
Finite nucleos(t)ide analog therapy for functional cure in HBeAg-negative chronic hepatitis B: Recent development in the paradigm shift
2天前
已完结
A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in chinese patients with chronic hepatitis B
5天前
已完结
皖公网安备34019202002308
